MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.
Introduction
A. Menarini Industrie Farmaceutiche Riunite S.r.l is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. This accessibility statement applies to the website www.menarini.com.
Compliance status
Partially compliant
This website partially complies with the requirements of appendix A of the EN 301549 standard.
Non-accessible content
A. Menarini Industrie Farmaceutiche Riunite S.r.l will update this section of the declaration with the list of non-accessible content and is committed to offer a digital experience accessible to all users. We are working to ensure that all of our content complies with the guidelines and standards set forth in the Web Content Accessibility Guidelines (WCAG) 2.1.
Preparation of this accessibility statement
This declaration was drawn up on 01/10/2025 by self-assessment.
Feedback and contact information
You can report any issues with accessing the website's content.
The report can be made by filling out the appropriate online form at this address: https://www.menarini.com/en-us/help-us-improve-accessibility.html
In the form, you will need to indicate:
- Name and surname;
- Address of the web page or sections of the website or customer area subject to the report;
- Clear and concise description of the problem encountered;
- Tools used (operating system, browser, assistive technologies).
Information on the website
- The date of publication of the website: 29/07/2025
- Usability tests have been carried out: No
- CMS used for website: Adobe Experience Manager